Key Takeaways
- Across 8,000+ comments, sentiment skews strongly positive. The most emotional word for the experience is not "weight," it is "quiet": the food noise going away
- People are on it for far more than weight loss. Type 2 diabetes, PCOS and insulin resistance, and even alcohol cravings show up constantly
- Side effects are discussed openly, not hidden. Nausea, constipation, and fatigue lead, with hair loss and muscle loss as the two big long-term fears
- The "easy way out" stigma is the loudest social objection, and users have a rehearsed set of comebacks ready for it
- Cost drives a large gray market. When insurance says no, people move to compounded tirzepatide through telehealth, comparing prices in the open
Roughly one in five US households now includes someone currently taking a GLP-1, up from about one in eleven at the start of 2025. That is a fast, enormous shift, and it happened mostly out of view of the brands trying to sell to these people. The public story is weight loss. The private story, the one people tell each other, is more complicated and more interesting.
So we did what we do: instead of guessing how people feel about these drugs, we read what they say when no brand is listening. This is a voice-of-customer study of more than 8,000 real comments from GLP-1 users, coded into why they take it, what it feels like, what goes wrong, and how they talk about the stigma and the cost. The goal was one honest read on sentiment, in their own words.
In a voice-of-customer analysis of 8,000+ comments from GLP-1 users, sentiment skewed strongly positive, but not mainly about weight. The most emotional recurring theme was relief from constant food noise, the background urge to eat that quiets on the drug. People also take it for diabetes, PCOS, and alcohol cravings. The biggest friction points are side effects, the "easy way out" stigma, and cost, which pushes many toward compounded tirzepatide through telehealth.
About this study
We gathered more than 8,000 unprompted public comments where people describe taking, starting, quitting, or debating GLP-1 drugs. Sources spanned the online communities where this audience actually talks: weight-loss, diabetes, and medication forums, plus wellness and general-health threads where the topic comes up.
Comments were coded by keyword and pattern into themes: why people take it, what it feels like when it works, the side effects, the stigma, cost and access, and how they compare brands. A single comment can be coded into more than one theme, so percentages are the share of coded mentions within a section, not a share of the full dataset. The figures below are directional estimates from this specific corpus, not a precise census. All quotes are verbatim, with only character-encoding artifacts cleaned up (the wording, spelling, and typos are the customer's own).
One important note, because this is a medication topic. Everything here describes how consumers talk and what they believe. None of it is medical advice or a claim about what these drugs do or do not do. We are studying language and sentiment, not clinical outcomes.
The research question
How do real GLP-1 users actually feel about these drugs, beyond the weight-loss headline? The short answer is that the sentiment is warmer than the public debate suggests, and the reason is rarely the number on the scale. It is the relief from a mental noise most people did not know had a name.
1. Why people are actually on it
The reasons behind the prescription · ranked by share of coded mentionsWeight loss is the headline, and it is the biggest single reason. But when you code the reasons people give, the drug looks less like a diet product and more like a metabolic and behavioral one. Diabetes, PCOS, and even drinking all show up as real, repeated motivations.
Weight loss, diabetes, and PCOS
The three medical anchors show up together often. Many users came for weight loss and found their blood sugar or PCOS symptoms improved. For a large group of women, insulin-resistant PCOS is the story that everything else hangs off.
"I was obese and always hungry because I have insulin resistant PCOS. I tried every diet and exercise plan on the planet. GLP1 is the only way I've ever lost a significant amount of weight."
"All I know is since I've been on a GLP1 my A1C as a diabetic has been so much better."
"She's prediabetic and is taking it to get blood sugar/insulin under control. A lot of people are. It isn't just taken to look better"
The alcohol surprise
One of the most consistent unprompted findings is that the drug quiets more than food. A recurring group says their desire to drink dropped or disappeared, which they did not expect and often welcome.
"This has actually done wonders for for me. Takes the desire to drink completely away"
"Currently in Retatrutide and have no desire to Drink alcohol. These GLP-1's are life changing for many people."
If you sell into this audience, "weight loss" is the shallowest way to reach them. The deeper, less crowded angles are metabolic health, PCOS and insulin resistance, and the behavioral quieting of cravings. The person in your funnel may not describe themselves as a dieter at all. They describe themselves as someone whose body finally works.
2. "That constant chatter is gone"
What it feels like when it worksAsk people to describe the effect and most of them do not lead with pounds. They lead with silence. The phrase "food noise" comes up constantly, and the relief of it stopping is the single most emotional thing in the entire dataset.
"That constant chatter is GONE. It literally brings me to tears."
"The food noise part catches people off guard the most."
"GLP-1s saved my life as I have PCOS."
"I don't care if I have to take this for the rest of my life. It has changed my life and I am so grateful for it."
The winning language is already written by the customers: "food noise," "the chatter is gone," "life-changing." This is emotional, not clinical. Copy that leads with a scale number talks past the feeling people actually buy for. If your product sits anywhere near this audience, mirror the relief, not the weight-loss claim.
3. The side effects that dominate the conversation
What goes wrong, in clusters, in their own wordsPositivity does not mean naivety. People talk about side effects openly and in detail. The near-term complaints are gut and energy related. The longer-term fears are about what the fast loss takes with it: hair and muscle.
"I'm Tirz and I'm about to get off because the nausea is killing me and I can barely eat. But in 11 weeks I lost 23 pounds."
"I started 10 days ago and I feel exactly like you. Extreme fatigue. Mild nausea. I have no energy. I just don't feel good."
"The constipation is killing me"
The second cluster is the loss people did not sign up for. Hair shedding and muscle loss are the two fears that make otherwise happy users anxious, and the advice that circulates is protein plus lifting.
"I am new to this group as I only recently started losing hair. The only change in my life is I started a GLP-1 6 months ago."
"It changed my life. Though I will say learn from my mistakes and WORK OUT. Lift weights. Force protein in your mouth. I lost so much muscle"
The side effects are not a secret, so pretending they do not exist reads as dishonest. For supplement, protein, and wellness brands, the openings are concrete: protein and creatine for muscle, hydration and electrolytes for the lost thirst cue, gentle regularity support for constipation. Speak to the specific fear, not a vague "support your journey."
4. "It's not the easy way out"
The stigma, and the comebacks people have readyThe single loudest social theme is the "easy way out" accusation, and it clearly stings. But it has also produced a whole vocabulary of rebuttals. People are tired of defending a choice that is working for them.
"It is definitely not the easy way out!!!!! I am putting in the effort to eat right and keep the food down! Putting up with nausea and feeling blah half the week"
"I got judged. It's actually not the "easy way out" it's a hard way that just actually works!"
"There is stigma and judgment no matter what you do"
The most effective response people describe is not arguing the science. It is disarming the judgment with open, cheerful honesty, which takes the moral charge out of the conversation.
"When I would get comments about my weight loss, I would happily exclaim "I'm on the drug, it's awesome!". Hard to get judgmental with someone so happy, honest, and upfront about it. Worked like a charm."
This audience is defensive for a reason, and shame-based marketing will backfire fast. The tone that lands is permission and matter-of-fact pride, not "finally, the shortcut." If your brand touches this space, help people feel normal and in control, not judged. The customers who are loudest and happiest are the ones who refused to feel embarrassed.
5. Cost, insurance, and the compounding gray market
How access shapes what people actually takeMoney is the practical thread running under everything. Coverage is inconsistent and often denied, and the price without it is high enough to change behavior. The recurring anxiety is that this is a lifelong drug with a lifelong bill.
"My insurance won't cover it and i can't afford it"
"It's expensive out of pocket and it's a lifelong med. That's my main issues w it"
When insurance says no, a large share of users route around it. Compounded tirzepatide through telehealth and compounding pharmacies is discussed openly, with named sources and monthly prices traded like tips. For the people it works for, the value verdict is blunt.
"I use lavender sky health for compounded tirzepatide. it has been less than $200 a month and i'm on high dose. Check it out."
"Go on the GLP1. My insurance used to cover but now I pay out of pocket. Worth every penny. I've lost 50lb in 10 months and have another 50lb to go."
The GLP-1 buyer is price-aware and community-informed. They compare sources, doses, and monthly costs in public and trust each other over official channels. Any brand adjacent to this market is being judged on transparency and value, not marketing spend. Vague premium positioning loses to a Reddit thread with a named pharmacy and a real number.
6. The brand landscape
How people compare Ozempic, Wegovy, Mounjaro, Zepbound and compoundsThe brand names are used loosely and interchangeably, but strong preferences exist. Tirzepatide products (Mounjaro, Zepbound) get compared favorably to semaglutide (Ozempic, Wegovy) by many, and the compounded generic version of Zepbound is a huge part of the conversation.
"Ozempic is terrible Zepbound is way better"
"Zepbound has been a game changer but I'm on the 10mg dose and the price is insane for self pay."
"I get my compounded tirzepatide (generic Zepbound) through PomegranateHealth. I pay ~$450 for a 3 mo's supply"
There is also a growing microdosing conversation, where people deliberately stay on low or maintenance doses to keep the benefit without fully killing hunger. It is framed as a smarter, gentler, and cheaper way to stay on the drug long term.
"Microdosing is the best way imo. Takes away the unsatiety and gives you freedom to eat everything you want without over eating usually"
The category vocabulary has already moved past "Ozempic" as a catch-all. Users distinguish semaglutide from tirzepatide, brand from compound, and full dose from microdose. If your copy still treats "Ozempic" as the whole category, you sound a step behind the people you are selling to. Match their precision and you earn credibility.
A customer glossary
The words this audience actually usesIf you write for this audience, these are the terms they already use fluently. Speaking them signals you understand the experience; getting them wrong signals you are on the outside looking in.
| Term | What customers mean | Signal |
|---|---|---|
| Food noise | The constant background urge to eat. Its quieting is the most-praised effect of the drug. | benefit |
| Tirz / sema / reta | Tirzepatide, semaglutide, retatrutide. Users name the molecule, not just the brand. | core |
| Compounded | A pharmacy-made version, usually tirzepatide, bought when insurance won't cover the brand. | access |
| Microdosing | Deliberately staying on a low dose to keep the benefit without killing appetite entirely. | behavior |
| Maintenance dose | The steady dose people plan to stay on long term, often for life. | behavior |
| Titrate / dose up | Moving to a higher dose, usually when effects fade or a plateau hits. | behavior |
| "Easy way out" | The stigma phrase users push back on hardest. A trigger, not a neutral term. | objection |
| Ozempic face | The gaunt look from fast fat loss. Shorthand for the cosmetic downside. | pain |
| Prior auth | Insurance pre-approval. A recurring, dreaded annual fight for coverage. | pain |
| Recomp | Rebuilding muscle while losing fat, the answer to the muscle-loss fear. | goal |
| Thirst cues | The signal to drink, which many lose. Why dehydration is a real risk here. | pain |
Frequently asked questions
What do people actually think about GLP-1 drugs?
In this corpus of 8,000+ comments, sentiment skews strongly positive, and the most emotional theme is not weight at all. Over and over, people describe relief from constant food noise, the background urge to eat that quiets on the drug. Many call it life-changing and say they are fine taking it long term. That positivity sits alongside honest talk about side effects, the fear of hair and muscle loss, the stigma of the easy way out, and the cost. It is enthusiasm with open eyes, not blind praise.
What are the most common reasons people take a GLP-1?
Weight loss is the biggest single reason, but it is far from the only one. Type 2 diabetes and blood sugar control come up constantly, as does food noise, binge eating, and emotional eating. A large share of women mention PCOS and insulin resistance. A smaller but very consistent group say the drug reduced or removed their desire to drink alcohol, and others cite inflammation and general medical reasons. The picture is closer to a metabolic and behavioral drug than a simple diet product.
What are the most talked-about side effects of GLP-1s?
Nausea and constipation dominate the complaint threads, followed by fatigue and low energy, especially in the first weeks and after dose increases. Two longer-term fears recur: hair loss and muscle loss, which push people toward high protein and lifting weights. Dehydration is a serious one, since many users lose their thirst cues. Most describe these as manageable trade-offs rather than deal-breakers, but a minority quit over nausea or hair loss specifically.
Why do people say GLP-1s are not the easy way out?
The easy way out is the loudest social objection in the data, and users have a rehearsed set of comebacks. They point out that they still have to eat right, force in protein, hit the gym, and put up with nausea for half the week. The common framing is that it is not easy, it is a hard thing that finally works, after years of diets that did not. Many describe judgment from family, coworkers, and strangers, and say the stigma is exhausting even when the results are good.
How do GLP-1 users deal with the cost?
Cost and access are a constant thread. When insurance covers it, people fight for prior authorizations and tier exceptions year after year. When it does not, a large share move to compounded tirzepatide through telehealth and compounding pharmacies, often paying around 200 to 450 dollars a month and openly comparing sources and prices. Others use manufacturer programs, patient assistance, or GoodRX coupons for the oral versions. The recurring worry is that this is a lifelong medication with a lifelong bill.
Want this run for your brand or category?
This is a public sample of how we work. Insightios reads Reddit, Amazon reviews, YouTube, and the communities where your buyers actually talk, then delivers a report with the exact language, objections, and use cases behind your product.
This report analyzes consumer language and perceptions. It is not medical advice and makes no claim about the safety or efficacy of GLP-1 medications or any product mentioned.